Clinical Trial Update: Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)

View source ↗

Summary

This document reports expanded access of axatilimab to treat a single patient with chronic graft-versus-host disease (GVHD). It provides status on compassionate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Axatilimab (axatilimab)

Snippet

Sponsor: Incyte Corporation | Conditions: Chronic Graft Vs. Host Disease | Status: AVAILABLE